Globally, around 60 million people live with psoriasis, a chronic autoimmune condition characterized by thick, red, scaly, itchy and often painful skin patches. In India, an estimated 0.44% to 2.8% of the population is affected, with a significant psychological and social impact on those affected and their families. As we observe World Psoriasis Day, it’s important to raise awareness about this condition and the advancements that are transforming lives.

In India, psoriasis primarily affects adults over 30 or 40, with men being twice as likely to develop it compared to women. However, psoriasis patients are at higher risk of related health issues like heart disease and metabolic syndrome, underscoring the need for comprehensive care.

Living with psoriasis goes beyond the visible symptoms. In India’s closely connected family structure, the emotional and social toll of psoriasis can impact the entire household. Unfortunately, the stigma and misconceptions around this non-contagious condition often lead to isolation and psychological distress for patients. Increasing awareness about psoriasis’ non-infectious nature can help reduce stigma and build a more inclusive community.

Fortunately, advancements in treatment are improving life for psoriasis patients. Innovative options, such as biologics targeting specific inflammatory pathways, have shown high efficacy with minimal side effects. Additionally, advanced oral immunomodulators provide intracellular treatment. These treatments are revolutionizing psoriasis care in India and globally.

At Glenmark, we are committed to advancing patient outcomes by offering effective, accessible therapies for psoriasis. Our focus on research, early diagnosis, and innovative treatments aims to support those impacted by this condition and help them achieve a better quality of life.

This World Psoriasis Day, let us come together to acknowledge the impact of psoriasis on individuals and families. Through increased awareness, support, and access to new treatments, we can make a meaningful difference in the lives of psoriasis patients in India and beyond.